Mucositis: continuing progress for a continuing need.
Stiff
Patrick J
PJ
Division of Hematology-Oncology, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, USA. pstiff@lumc.edu
D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects; D004311:Double-Blind Method; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006301:Health Services Needs and Demand; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D008558:Melphalan / Q000009:adverse effects; D052016:Mucositis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D020380:Needs Assessment; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D014481:United States
D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan